Kiri Industries Limited · NSE:KIRIINDUS
Kiri Industries — Q3 FY2020 Earnings Presentation
27 slides from Kiri Industries's earnings presentation, Feb 13, 2020
Slide 1: Intimation of Earnings Conference Call and Presentation
CD Kiri Industries Limited ~{i:fto{ C'~..... February 12, 2020 To, To, BSE Limited National Stock Exchange of India Limited st 1 Floor, Rotunda Building, Exchange Plaza, Bandra Kurla Complex, B.S. Marg, Fort, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 532967 Scrip 10 - KIRIINOUS -----
Slide 2: Earnings Con-call Invite
Earnings Con-call Invite VALOREM ADVISORS is pleased to invite you for a Conference Call to discuss 9M / Q3-FY20 earnings of on Thursday 13th February, 2020 at 2:00 pm Kiri Industries Limited’s Management will be represented by: Mr. Manish Kiri – Managing Director Mr. Jayesh Hirani – Senior Manager
Slide 3: Kiri Industries Limited 9M / Q3-FY20 Earnings Presentation
Kiri Industries Limited 9M / Q3-FY20|EARNINGS PRESENTATION
Slide 4: Company Overview
2 Company Overview • Established in 1998, Kiri Industries Limited (KIL), Consolidated Revenue Break-up (INR Mn) is based out of Gujarat and has emerged as one 6,625 of the largest manufacturers and exporters of a 4,629 wide range of Dyes, Dyes Intermediates and 3,681 4,879 5,261 Basic Chemicals from
Slide 5: About DyStar
3 About DyStar Total Revenue (USD Mn) KIL acquired Dystar in 2010, along with Zhenjiang 1,129 1,016 1057 Longsheng holding 37.57% presently 938 898 822 871 • The DyStar Group is a leading dyestuff and chemical manufacturer and solution provider, offering a broad portfolio of colorants, specialty che
Slide 6: History
4 History COLORATION SPECIALIST FOUNDATION JOINT VENTURE OF: ACQUISITION: Bayer AG and Emerald Hoechst AG Performance (Textile dyes, ACQUISITION: FOUNDATION: Materials SOLUTION Ind. Color Solutions ACQUISITION: Sustainable Specialities SUSTAINABILITY LEADER PROVIDER Mitsubishi) International Texania
Slide 7: 9M / Q3-FY20 Financial Highlights
5 9M / Q3-FY20 Financial Highlights Q3-FY20 Financial Highlights (Standalone) Q3-FY20 Financial Highlights (Consolidated) • Operational Revenue: INR 2,267 Mn • Operational Revenue: INR 3,151 Mn • EBITDA: INR 225 Mn • EBITDA: INR 417 Mn • EBITDA Margin: 9.93% • EBITDA Margin: 13.23% • Net Profit: INR
Slide 8: Q3-FY20 Operational & Financial Highlights
6 Q3-FY20 Operational & Financial Highlights • Kiri adapted a concentrated approach on penetrating local markets for sale of dyes and dyes intermediates to beat economic contraction in the global business environment. During the current quarter the company concentrated on volume growth across the pr
Slide 9: Update on Kiri's suit in the matter of DyStar
7 Update on Kiri’s suit in the matter of DyStar • As per directions of Singapore International Commercial Court (“SICC”) hearing of Case SIC -4 (Company’s minority oppression suit) for valuation of the Company’s stake is fixed the hearing dates for the valuation trial between February 26 and 28 2020
Slide 10: 9M / Q3-FY20 Financial Highlights
9M / Q3-FY20 Financial Highlights
Slide 11: Q3-FY20 Standalone Income Statement
9 Q3-FY20 Standalone Income Statement PARTICULARS (INR Mn) Q3-FY20 Q3-FY19 Y-o-Y Q2-FY20 Q-o-Q Revenue from Operations 2,267 2,339 (3.1)% 2,516 (10)% Total Expenses 2,042 2,024 0.9% 2,268 (9.9)% EBITDA 225 315 (28.6)% 248 (9.3)% EBITDA Margin(%) 9.93% 13.47% (354) Bps 9.87% 6 Bps Other Income 13 2 N
Slide 12: Q3-FY20 Standalone Financial Highlights
10 Q3-FY20 Standalone Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) 315 2,267 2,339 225 Q3-FY20 Q3-FY19 Q3-FY20 Q3-FY19 PAT (INR Mn) EBITDA Margin & PAT Margin 221 13.47% 9.93% 113 9.45% 4.98% Q3-FY20 Q3-FY19 Q3-FY20 Q3-FY19 EBITDA (%) PAT (%)
Slide 13: 9M-FY20 Standalone Income Statement
11 9M-FY20 Standalone Income Statement PARTICULARS (INR Mn) 9M-FY20 9M-FY19 Y-o-Y Operational Income 7,565 7,570 (0.1)% Total Expenses 6,712 6,350 5.7% EBITDA 853 1,220 (30.1)% EBITDA Margin (%) 11.28% 16.12% (484) Bps Other Income 22 12 83.3% Depreciation 263 202 30.2% Finance Cost 31 32 (3.1)% PBT
Slide 14: 9M-FY20 Standalone Financial Highlights
12 9M-FY20 Standalone Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) 7,565 7,570 1,220 853 9M-FY20 9M-FY19 9M-FY20 9M-FY19 PAT (INR Mn) EBITDA Margin & PAT Margin 981 16.12% 11.28% 502 12.96% 6.64% 9M-FY20 9M-FY19 9M-FY20 9M-FY19 EBITDA (%) PAT (%)
Slide 15: Q3-FY20 Consolidated Income Statement
13 Q3-FY20 Consolidated Income Statement PARTICULARS (INR Mn) Q3-FY20 Q3-FY19 Y-o-Y Q2-FY20 Q-o-Q Revenue from Operations 3,151 3,018 4.4% 3,256 (3.2)% Total Expenses 2,734 2,580 6.0% 2,738 (0.1)% EBITDA 417 438 (4.8)% 518 (19.5)% EBITDA Margin 13.23% 14.51% (128) Bps 15.91% (268) Bps Other Income 1
Slide 16: Q3-FY20 Consolidated Financial Highlights
14 Q3-FY20 Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) 3,151 438 3,018 417 Q3-FY20 Q3-FY19 Q3-FY20 Q3-FY19 PAT (INR Mn) EBITDA Margin & PAT Margin 267 14.51% 13.23% 241 7.65% 8.85% Q3-FY20 Q3-FY19 Q3-FY20 Q3-FY19 EBITDA (%) PAT (%)
Slide 17: 9M-FY20 Consolidated Income Statement
15 9M-FY20 Consolidated Income Statement PARTICULARS (INR Mn) 9M-FY20 9M-FY19 Y-o-Y Operational Income 10,071 10,079 (0.1)% Total Expenses 8,518 8,239 3.4% EBITDA 1,553 1,840 (15.6)% EBITDA Margin 15.42% 18.26% (284) Bps Other Income 31 13 NA Depreciation 330 269 22.7% Finance Cost 33 40 (17.5)% PBT
Slide 18: 9M-FY20 Consolidated Financial Highlights
16 9M-FY20 - Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) 10,071 10,079 1,840 1,553 9M-FY20 9M-FY19 9M-FY20 9M-FY19 PAT (INR Mn) EBITDA Margin & PAT Margin 1,313 18.26% 15.42% 975 13.03% 9.68% 9M-FY20 9M-FY19 9M-FY20 9M-FY19 EBITDA (%) PAT (%)
Slide 19: Historical Financials
> NP HISTORICAL FINANCIALS
Slide 20: Standalone Income Statement
18 Standalone Income Statement PARTICULARS (INR Mn) FY16** FY17** FY18 FY19 9M-FY20 Revenue from Operations 9,557 10,335 9,013 10,619 7,565 Total Expenses 8,733 9,059 7,712 9,055 6,712 EBITDA 824 1,276 1,301 1,564 853 EBITDA Margin 8.62% 12.35% 14.43% 14.73% 11.28% Other Income 79 20 33 28 22 Deprec
Slide 21: Standalone Balance sheet
19 Standalone Balance sheet PARTICULARS (INR Mn) FY18 FY19 H1-FY20 PARTICULARS (INR Mn) FY18 FY19 H1-FY20 Equity 5,109 6,307 6,620 Non Current Assets 5,554 6,922 7,476 Equity Share Capital 302 313 336 a) Property, Plant and Equipment 3,485 4,290 4,679 Other Equity 4,807 5,994 6,284 b) Other Intangib
Slide 22: Consolidated Income Statement
20 Consolidated Income Statement PARTICULARS (INR Mn) FY16** FY17** FY18 FY19 9M-FY20 Revenue from Operations 11,119 11,983 11,352 13,938 10,071 Total Expenses 9,880 10,393 9,542 11,628 8,518 EBITDA 1,239 1,590 1,810 2,310 1,553 EBITDA Margin (%) 11.14% 13.27% 15.94% 16.57% 15.42% Other Income 13 24
Slide 23: Consolidated Balance sheet
21 Consolidated Balance sheet PARTICULARS (INR Mn) FY18 FY19 H1-FY20 PARTICULARS (INR Mn) FY18 FY19 H1-FY20 Equity 14,047 15,673 16,862 Non Current Assets 14,286 15,673 16,722 Equity Share Capital 302 313 336 a) Property, Plant and Equipment 4,033 4,769 5,131 Other Equity 13,745 15,360 16,526 b) Oth
Slide 24: Consolidated Financial Highlights
22 Consolidated Financial Highlights Total Revenue (INR Mn) EBITDA (INR Mn) & PAT(INR Mn) & PAT 13,938 EBITDA Margins (%) Margins(%) 11,983 11,352 11,119 15.94% 16.57% 13.27% 11.14% 11.16% 11.31% 9.14% 2.49% 1,239 1,590 1,810 2,310 257 1,095 1,267 1,576 FY16 FY17 FY18 FY19 FY16 FY17 FY18 FY19 FY16 F
Slide 25: Capital Markets
23 Capital Markets Share Price Data as on 31st December 2019 40% 30% 20% 10% 0% -10% -20% -30% Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Kiri Sensex Price Data (31st December, 2019) INR Shareholding Pattern as on 31st December, 2019 Face Value 10.0 Market Pr
Slide 26: Disclaimer
24 Disclaimer Kiri Industries Limited Disclaimer: The information contained in this presentation is only current as of its date. All actions and statements made herein or otherwise shall be subject to the applicable laws and regulations as amended from time to time. There is no representation that a
Slide 27: Thank You
THANK YOU